Obiri N I, Siegel J P, Varricchio F, Puri R K
Division of Cellular and Gene Therapies, FDA, Bethesda, MD 20892.
Clin Exp Immunol. 1994 Jan;95(1):148-55. doi: 10.1111/j.1365-2249.1994.tb06029.x.
It has previously been shown that murine sarcoma cells express high-affinity IL-4 receptors (IL-4R) which are internalized after binding to the ligand (Puri et al., Cancer Res 1991; 51:3011-7). We have also reported that human renal cell carcinoma cells express high-affinity IL-4R, and IL-4 inhibits tumour growth in vitro (Obiri et al., J Clin Invest 1993; 91:88). In this study we investigated the expression and function of IL-4R on other human solid tumours. Human melanoma, ovarian carcinoma and breast carcinoma cell lines were assessed for the cell surface expression of IL-4R by radio-ligand receptor binding and for IL-4R gene expression by Northern blot analysis. Primary cultures of mesothelioma and neurofibrosarcoma cells were similarly investigated. Human melanoma, ovarian carcinoma and breast carcinoma cell lines expressed IL-4R on their cell surface with a dissociation constant (Kd) of 140-549 pM. These tumour lines expressed a single 4 kb species of mRNA for IL-4R. Similarly, primary cultures of mesothelioma and neurofibrosarcoma cells were positive for the IL-4R mRNA by Northern blot analysis. Fresh, non-cultured mesothelioma and neurofibrosarcoma tumour sections were also positive for the presence of IL-4R as determined by immunohistochemistry of frozen sections using anti-IL-4R antibody. In order to study possible functions of IL-4R, we evaluated the effects of IL-4 on cell growth and its effect on MHC antigen expression in the presence or absence of interferon-gamma (IFN-gamma). In tissue culture, IL-4 reduced the growth of tumour cell lines and primary cell cultures studied. IL-4 had very little effect on MHC class I antigen expression on ovarian, breast and melanoma cell lines; however, MHC class II (HLA-DR) expression was enhanced on melanoma and breast carcinoma cells. IL-4 also enhanced the IFN-gamma-induced class II expression on melanoma and breast carcinoma cells. Taken together, our observations indicate that IL-4R are expressed on a variety of human solid tumours and these receptors may be functional. IL-4 alone and in combination with IFN-gamma may play a role in host immune response against cancers.
先前的研究表明,鼠肉瘤细胞表达高亲和力的白细胞介素-4受体(IL-4R),该受体与配体结合后会被内化(普里等人,《癌症研究》1991年;51:3011 - 7)。我们也报道过,人肾癌细胞表达高亲和力的IL-4R,并且IL-4在体外可抑制肿瘤生长(奥比里等人,《临床研究杂志》1993年;91:88)。在本研究中,我们调查了IL-4R在其他人类实体瘤中的表达和功能。通过放射性配体受体结合法评估人黑色素瘤、卵巢癌和乳腺癌细胞系IL-4R的细胞表面表达情况,并通过Northern印迹分析评估IL-4R基因的表达情况。对间皮瘤和神经纤维肉瘤细胞的原代培养物进行了类似的研究。人黑色素瘤、卵巢癌和乳腺癌细胞系在其细胞表面表达IL-4R,解离常数(Kd)为140 - 549 pM。这些肿瘤细胞系表达一种单一的4 kb的IL-4R mRNA。同样,通过Northern印迹分析,间皮瘤和神经纤维肉瘤细胞的原代培养物的IL-4R mRNA呈阳性。使用抗IL-4R抗体对新鲜的、未培养的间皮瘤和神经纤维肉瘤肿瘤切片进行冷冻切片免疫组织化学检测,结果也显示IL-4R呈阳性。为了研究IL-4R可能的功能,我们评估了IL-4在有或无干扰素-γ(IFN-γ)存在的情况下对细胞生长的影响及其对MHC抗原表达的影响。在组织培养中,IL-4降低了所研究的肿瘤细胞系和原代细胞培养物的生长。IL-4对卵巢癌、乳腺癌和黑色素瘤细胞系上的MHC I类抗原表达影响很小;然而,黑色素瘤和乳腺癌细胞上的MHC II类(HLA-DR)表达增强。IL-4还增强了IFN-γ诱导的黑色素瘤和乳腺癌细胞上的II类表达。综上所述,我们的观察结果表明,IL-4R在多种人类实体瘤中表达,并且这些受体可能具有功能。单独的IL-4以及与IFN-γ联合使用可能在宿主针对癌症的免疫反应中发挥作用。